Atezolizumab vs Canagliflozin

## Atezolizumab vs Canagliflozin: Overview

This comparison examines the pharmacological differences between **Atezolizumab** and **Canagliflozin**.

## Mechanism of Action

**Atezolizumab**: Fully human anti-PD-L1 IgG1 monoclonal antibody blocking PD-L1 interaction with PD-1 and B7.1.

**Canagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption and lowering blood glucose.

## Pharmacokinetics

**Half-life**: Atezolizumab — 27 days; Canagliflozin — 10.6 hours.

## Chemical Properties

**Molecular Formula**: Atezolizumab — N/A; Canagliflozin — C24H25FO5S.

**Molecular Weight**: Atezolizumab — N/A; Canagliflozin — 444.5170 g/mol.

**Type**: Atezolizumab — Antibody; Canagliflozin — Small molecule.